CM Hospitalar SABMFBOVESPA: VVEO3

CM Hospitalar: Margin expansion and cash generation drive improved leverage and growth in Q2 2025

· Issued by CM Hospitalar SA

Q2 2025 saw 2.5% revenue growth and 6.8% gross profit increase, with margin expansion driven by contract renegotiations and strong retail and vaccine performance. Leverage improved to 4.33x, and cash generation remains a key focus for H2.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

CM Hospitalar SA on 6ix

Earlier from CM Hospitalar

Later from CM Hospitalar

All CM Hospitalar news releases